Praxis Precision Medicines (PRAX) Cash & Current Investments: 2022-2025
Historic Cash & Current Investments for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $267.2 million.
- Praxis Precision Medicines' Cash & Current Investments fell 25.17% to $267.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 29.21%. This contributed to the annual value of $392.6 million for FY2024, which is 382.86% up from last year.
- Praxis Precision Medicines' Cash & Current Investments amounted to $267.2 million in Q3 2025, which was down 11.32% from $301.3 million recorded in Q2 2025.
- Praxis Precision Medicines' 5-year Cash & Current Investments high stood at $392.6 million for Q4 2024, and its period low was $56.0 million during Q2 2022.
- For the 3-year period, Praxis Precision Medicines' Cash & Current Investments averaged around $235.7 million, with its median value being $267.2 million (2025).
- Per our database at Business Quant, Praxis Precision Medicines' Cash & Current Investments skyrocketed by 382.86% in 2024 and then decreased by 25.17% in 2025.
- Praxis Precision Medicines' Cash & Current Investments (Quarterly) stood at $61.6 million in 2022, then soared by 31.95% to $81.3 million in 2023, then skyrocketed by 382.86% to $392.6 million in 2024, then dropped by 25.17% to $267.2 million in 2025.
- Its Cash & Current Investments stands at $267.2 million for Q3 2025, versus $301.3 million for Q2 2025 and $328.0 million for Q1 2025.